On 1 and 2 November the 12th edition of the Radboud New Frontiers symposium will take place. During the first day of this symposium we will explore what big data and healthcare data science have to offer for personalized healthcare. This day is targeted at researchers but open for everyone with interest in the subject. Registration will open soon!With new scientific insights and increasing technological possibilities medical research is rapidly changing. Increased computer capacity, availability of data and connectivity between databases enable big data analysis and have propelled the development of fields such as multi-omics, network medicine and computational medicine. In combination with demographic changes such as the rise of lifestyle related and chronic diseases, insights derived from the application of these new methodologies change the way we look at diseases: what once was one disease increasingly turns out to be a collection of entities with their own etiology, diagnosis and treatment. Vice versa, we begin to understand how health and disease are inherently multiscale phenomena that emerge out of complex and dynamic interactions within and between a person and his environment. Technologies like lab on a chip and self measurement with all kind of sensors change the way we collect data to make a diagnosis and the way we monitor diseases. In the background we see that the complexity of healthcare delivery and organisation has increased, not always in favour of the patient. However, the essence of medicine remained; the impact on patients’ lives of being confronted with illness and the importance of the caring relationship in a patient journey.
In this context, the topic of this conference is to explore what big data and healthcare data science have to offer for (research into) personalized healthcare:
- what is the potential promise of big data application to healthcare;
- what are examples of successful application of data science and how can these be applied to benefit health;
- what are the technical, organizational, ethical and epistemological limitations of the application of data science in the field of health;
- and will big data help to bridge the divide between medicine-as-a-science and medicine-as-an-art, and improve the individual patient journey?
Want to know more about these subjects? Click on the buttons below for more news.
RIMLSRIHSHealthcare improvement scienceNanomedicine Cancer development and immune defenseRare cancersTumors of the digestive tract Urological cancersWomen's cancersInfectious diseases and global healthInflammatory diseases Mitochondrial diseasesReconstructive and regenerative medicineRenal disorders Vascular damage Sensory disordersAlzheimer’s diseaseDisorders of movementNeurodevelopmental disordersStress-related disordersDonders Institute
Related news items
In order to maximize quality of life in pediatric psoriasis reaching for clear skin is necessary12 December 2019
In JAMA Dermatology, Bruins et al showed that greatest improvement in quality of life was achieved with 90% improvement of the Psoriasis Area and Severity Index (PASI) and 90% decrease of affected body surface area in a large cohort of children with psoriasis.read more
Bart-Jan Kullberg appointed as Chair of Health Council12 December 2019
As of 1 January 2020, Bart-Jan Kullberg has been appointed as the Chairperson of the Health Council of the Netherlands.read more
Vote for the Supervisor of the year12 December 2019
Now you have the chance to vote for your preferred candidate. Have fun, and go for it, support and promote the ideal supervisor. Deadline for voting is 5 January 2020. The three nominated finalists are: Joost Drenth, Marien de Jonge and Iris Nagtegaal.read more
Jelle Barentsz's trilogy of educational papers in European Urology12 December 2019
Recently, a trilogy of educational papers by our full professor Jelle Barentsz has been published in European Urology. The publications address what urologists need to know about prostate-MRI.read more
ERC Consolidator Grant for Bousema and Sechopoulos12 December 2019
Teun Bousema and Ioannis Sechopoulos each receive an ERC Consolidator Grant of around two million euros. This European research subsidy will enable them to carry out research for the next five years.read more